Skip to main content

XLV

ETF

XLV

ETF
Health Care
ETF

Performance overview

XLV Price
Price Chart

Forward-looking statistics

Beta
0.48
Risk
11.86%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

An ETF that seeks to provide investment results corresponding to the performance of the Health Care Select Sector Index.

Fund info

An ETF that seeks to provide investment results corresponding to the performance of the Health Care Select Sector Index.

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.08%
Asset classEquities

Company info

SectorHealth Care
IndustryETF
Website
AUM$39.3B

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)
Dividend per share$2.26
Revenue per share
Avg trading volume (30 day)$2B
Avg trading volume (10 day)$2B
Put-call ratioN/A

Macro factor sensitivity

Growth+0.8
Credit+1.9
Liquidity-0.1
Inflation-1.7
Commodities+0.1
Interest Rates-0.8

Upcoming events

Next earnings dayFebruary 15, 2005
Next dividend day
Ex. dividend dayMarch 24, 2025

News

June Jobs Data Puts Focus on Healthcare ETFs & Stocks

June's solid jobs report, with 39K new roles in healthcare, may boost the outlook for ETFs like XLV, IHF, VHT and stocks like HCA, WELL, OHI.

Zacks Investment Research (July 7, 2025)
I've never seen a setup this negative for health care job growth, says Bancreek's Pachman

CNBC's 'Power Lunch' is joined by Eric Pachman, chief analytics officer at Bancreek Capital Advisors, to discuss the U.S. labor market, whether health care jobs are in jeopardy and more.

CNBC Television (June 12, 2025)
How pet medicine stocks could cushion your healthcare investments from Trump changes

Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F.

Yahoo Finance (June 2, 2025)
Trump Says Pharmaceutical Tariffs Coming in Near Future

President Donald Trump said tariffs on pharmaceuticals will be coming in the 'not too distant future' and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with reporters Monday in the Oval Office.

Bloomberg Markets and Finance (April 14, 2025)
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC.  The tariffs could disrupt the complex pharmaceutical supply chain, potentially driving up the prices of drugs in the U.S. and exacerbating shortages of critical medicine.

CNBC (April 11, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free